Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
112 Cards in this Set
- Front
- Back
Lymphatic system
|
body system that includes lymph, lymphatic vessels, lymphatic tissue,lymphatic nodules, lymph nodes, tonsils, the spleen, and the thymus
|
|
List three functions of the lymphatic system
|
1) fluid balance
2) fat absorption 3) defense |
|
Lymph
|
excess fluid passed from the bloodstream into bodily tissues accumulates and drains into lymphatic capillaries where it passes back into the circulatory system, this fluid is called lymph;
contains water, substances normally found in plasma, and substances derived from cells (hormones, enzymes, and waste) |
|
Lacteals
|
special lymphatic vessels that are located in the lining of the small intestine;
fats enter these vessels and pass through lymphatic vessels to the venous circulation |
|
Chyle
|
lymph passing through lacteals;
has a milky appearance due to its fat content |
|
Lymphatic capillaries
|
small dead-end tubes into which extra fluids from the body tissues enter into and becomes lymph;
differ from blood capillaries in that they lack a basement membrane and that cells of the simple squamous epithelium ovelap and are loosely connected |
|
Lymphatic vessels
|
formed by the merging of lymphatic capillaries;
resemble small veins; consists of three layers and contains one-way valves that keep lymph flowing in a single direciton |
|
What are three factors that are responsible for the movement of lymph through lymphatic vessels?
|
1) contraction of surrounding skeletal muscles during activity
2) periodic contraction of the smooth muscles in the lymphatic vessel walls 3) pressure changes in the thorax during respiration |
|
Lymph nodes
|
round, oval (or bean-shaped) bodies distributed along the various lymphatic vessels;
function to filter lymph |
|
Lymphatic trunks
|
lymphatic vessels converge to form lymphatic trunks, which drain major portions of the body;
juglar, subclavian, bronchomediastinal, intestinal, lumbar trunks |
|
Lymphatic ducts
|
larger vessels which connect lymphatic trunks to large veins
|
|
Right lymphatic duct
|
drains the right side of the head, right-upper limb, and right thorax
|
|
Thoracic duct
|
drains the right side of the body inferior to the thorax and the entire left side of the body
|
|
Lymphatic tissue
|
tissue that consists of primarily lymphocytes, but also includes macrophages, dendritic cells, reticular cells, and other cell types
|
|
Lymphocytes
|
a type of white blood cell that originates from red bone marrow and carried by blood to lymphatic organs and other tissues;
divide in response to microorganisms and foreign pathogens |
|
Reticular fibers
|
very fine collagen fibers contained within lymphatic tissue;
produced by reticular cells; lmphocytes and other cells attach to these fibers and forms a network that traps microorganisms and other particles in the lymph |
|
Mucosa-associated lymphoid tissue (MALT)
|
aggregates of nonencapsulated (no connective tissue layering) lymphatic tissue found in and beneath the mucous membranes lining the digestive, respiratory, urinary, and reproductive tracts
|
|
Diffuse lymphatic tissue
|
contains dispersed lymphocytes, macrophages, and other cells;
has no clear boundary and blends with surrounding tissues; located deep to mucous membranes, around lymphatic nodules and within lymph nodes and spleen |
|
Lymphatic nodules
|
denser arrangements of lymphoid tissue organized into compact, somewhat spherical structures;
numerous in loose connective tissue of the digestive, respiratory, urinary, and reproductive systems |
|
Peyer's patches
|
aggregations of lymphatic nodules found in the distal half of the small intestine and the appendix
|
|
Tonsils
|
large groups of lymphatic nodules and diffuse lymphatic tissue located deep to the mucous membranes with the pharynx;
provide protection against bacteria and other potentially harmful material entering the pharynx from the nasal or oral cavities; decrease in size in adults |
|
Lymph nodes
|
small, round structures located along the course of the lymphatic vessels;
filter lymph; sight of lymphocyte congregation, function, and proliferation |
|
Germinal centers
|
areas of rapid lymphocyte division found in lymph nodes and especially in the lymphatic nodules of the cortex
|
|
Afferent lymphatic vessels
|
vessels that carry lymph to the lymph nodes
|
|
Efferent lymphatic vessels
|
vessels that carry lymph away from the nodes
|
|
Spleen
|
a lymphatic organ that is roughly the size of a clenched fist and is located on the left side in the extreme, superior part of the abdominal cavity;
destroys defective red blood cells, detects and responds to foreign substances in the blood, and acts as a blood reservoir |
|
White pulp
|
lymphatic tissue surrounding the arteries within the spleen
|
|
Red pulp
|
lymphatic tissue associated with the veins in the spleen;
consists of a fibrous network, filled with macrophages and red blood cells, and enlarged capillaries that connect to the veins |
|
Periarterial lymphatic sheath
|
diffuse lymphatic tissue surrounding arteries and arterioles extending to lymphatic nodules
|
|
Splenic cords
|
a network of reticular cells within the spleen which produce reticular fibers
|
|
Venous sinuses
|
enlarged capillaries between the splenic cords
|
|
Thymus
|
a bilobed gland located in the superior mediastinum;
thought to increase in size until the first year of life; site of maturation of T lymphocytes |
|
Immunity
|
the ability to resist damage from foreign substances such as microorganisms and harmful chemicals;
categorizes as either innate immunity and adaptive immunity |
|
Innate (non-specific) immunity
|
immune response in which the body recognizes and destroys certain foreign substances, but the responses to them is the same each time the body is exposed to them
|
|
Adaptive (specific) immunity
|
immune response in which the body recognizes and destroys foreign substances, but the response to them improves each time the foreign substance is encountered
|
|
Specificity
|
the ability of adaptive immunity to recognize a particular substance
|
|
Memory
|
the ability of adaptive immunity to "remember" previous encounters with a particular substance, resulting in a faster, stronger, and longer lasting response
|
|
Mechanical mechanisms
|
barriers that form the first line of defense against pathogens;
skin, mucous membranes; either form barrier to prevent entry into body, or secrete chemicals that impede organisms from getting in |
|
Chemical mediators
|
molecules responsible for many aspects of innate immunity;
found on the surface of cells, in chemicals secreted by cells, etc.; lysozyme, sebum, mucus, histamine, complement |
|
Complement
|
a group of about 20 proteins that make up approximately 10% of the globulin part of serum;
include proetins named C1-C9 and factors B, D, and P; aid in innate immune response |
|
Complement cascade
|
a series of reactions in which each component of the series activates the next component;
complement normally circulates in the bloodstream inactivated |
|
Alternative pathway
|
part of innate immunity and is initiated when complement protein C3 becomes spontaneously active;
activated C3 can combine with some foreign substances, become stabilized, and activate the complement cascade |
|
Classical pathway
|
part of the adaptive immune system;
initiated by the constant region of antibodies; stimulates inflammation; attracts neutrophils, monocytes, macrophages, and eosinophils to sites of infection; and kills bacteria by lysis |
|
Membrane attack complex (MAC)
|
can be formed by activated complement proteins;
produces a channel through the plasma membrane of pathogen cell, causing the cell to lyse |
|
Interferons
|
proteins that protect the body against viral infection and perhaps some forms of cancer
|
|
Chemotactic factors
|
parts of microbes or chemicals released by tissue cells that act as chemical signals to attract white blood cells;
i.e., complement, leukotrienes, kinins, histamine |
|
Chemotaxis
|
the ability of some cells to detect and move from areas of low chemical concentration to areas of higher chemical conc.;
move toward the source of a chemotactic factor |
|
Phagocytosis
|
the endocytosis and destruction of particles by cells
|
|
Neutrophils
|
small phagocytic cells produced in large numbers in red bone marrow that are released into the blood;
usually the first cells to enter infected tissues in large number and often die after a single phagocytic event; release lysosomal enzymes that kill microorganisms and cause tissue damage and inflammation |
|
Pus
|
an accumulation of dead neutrophils, dead microorganisms, debris from dead tissue, and fluid
|
|
Macrophages
|
large phagocytic cells that are called monocytes when found in blood;
outlive neutrophils and ingest more and larger particles; accumulate in tissues after neutrophils and are responsible for most phagocytic activity late in an infection; produce interferons, prostaglandins, and complement |
|
Basophils
|
motile white blood cells that are derived from red bone marrow and can leave the blood and enter infected tissues;
can be activated through specific or non-specific immunity; release inflammatory chemicals, histamine, leukotrienes |
|
Mast cells
|
nonmotile cells in connective tissue, located at potential points of entry of microorganisms into the body;
can be activated through specific or non-specific immunity; release inflammatory chemicals, histamine, leukotrienes |
|
Eosinophils
|
white blood cells produced in red bone marrow, leave bloodstream within a few minutes;
releases enzymes that break down chemicals released by basophils and mast cells; contain and reduce the inflammatory response |
|
Natural killer (NK) cells
|
a type of lymphocyte produced in red bone marrow, account for 15% of lymphocytes;
recognize general classes of cells and release chemicals that cause the cells to lyse |
|
Inflammatory resposne
|
a complex sequence of events involving many of the chemical mediators and cells of innate immunity;
caused by tissue injury |
|
Local inflammation
|
an inflammatory response confined to a specific area of the body;
symptoms include redness, heat, swelling, pain, and loss of function |
|
Systemic inflammation
|
an inflammatory response that occurs in many parts of the body;
symptoms include redness, heat, swelling, pain, and loss of function, as well as the release of large numbers of neutrophils by red bone marrow, the release of pyrogens that stimulate fever production, and in severe cases, vaso-permeability increases dramatically |
|
Pyrogens
|
chemicals released by microorganisms, macrophages, neutrophils, and other cells, that stimulate fever production
|
|
Antigens
|
substances that stimulate adaptive or specific immunity;
usually large molecules |
|
Haptens
|
small molecules capable of combining with larger molecules like blood proteins to stimulate an adaptive immune system response
|
|
Foreign antigens
|
antigens that are not produced by one's one body, but are introduced from outside of it
|
|
Allergic reaction
|
an overreaction of the immune system that can be stimulated by pollen, animal dander, foods, drugs, etc.
|
|
Self-antigens
|
molecules produced by the body that stimulate an adaptive immune system response;
can be beneficial or harmful |
|
Autoimmune disease
|
a condition that can result when self-antigens stimulate unwanted tissue destruction
|
|
Humoral immunity (antibody-mediated immunity)
|
immunity due to antibodies in serum;
effective against extracellular antigens such as bacteria, viruses, protozoans, fungi, parasites, and toxins when they are outside cells |
|
Cell-mediated immunity
|
immunity due to the actions of T cells and null cells
|
|
B cells
|
lymphocytes that give rise to cells that produce antibodies
|
|
T cells
|
lymphocytes that are responsible for cell-mediated immunity
|
|
Effector T cells
|
T cells that are responsible for producing the effects of cell-mediated immunity;
i.e., cytotoxic T cells and delayed hypersensitivity T cells |
|
Regulatory T cells
|
T cells that promote or inhibit the activites of both antibody-medaited immunity and cell-mediated immunity
i.e., helper T cells, suppressor T cells |
|
Positive selection
|
a process that results in the survival of pre-B and pre-T cells that are capable of an immune response
|
|
Negative selection
|
a process that eliminates or suppresses clones acting against self-antigens, thereby preventing the destruction of self-cells;
occurs mostly during prenatal development, but continues throughout life |
|
Primary lymphatic organs
|
the sites where lymphocytes mature into functional cells;
red bone marrow and thymus |
|
Secondary lymphatic tissues
|
the sites where lymphocytes interact with each other, antigen-presenting cells, and antigens to produce an immune response;
diffuse lymphatic tissue, lymphatic nodules, tonsils, lymph nodes, spleen |
|
Antigenic determinants (Epitopes)
|
specific regions of a given antigen recognized by a lymphocyte;
each antigen has many different antigenic determinants |
|
Antigen receptors
|
surface proteins found on lymphocyte clones that combines with antigenic determinant;
specific to each antigen; result is similar to the lock-and-key model for enzymes |
|
T-cell receptor
|
consists of two polypeptide chains, which are subdivided into a variable and a constant region;
variable region can bind to an antigen, different T cells have receptors with different variable regions |
|
B-cell receptor
|
consists of four polypeptide chains with two identical variable regions, a type of antibody
|
|
Major histocompatibility complex (MHC) molecules
|
glycoproteins located on the surface of cells that are responsible for most lymphocyte activation;
attached to plamsa membranes and have a variable region that can attach to foreign and self-antigens |
|
MHC class I molecules
|
MHC molecules found on nucleated cells and function to display antigens produced inside the cells on their surfaces;
allow a way for the immune system to respond to problems within a cell, such as viruses; viral proteins attach to these molecules and they migrate to cell surface form MHC class I/antigen complex, activating T cells; stimulates destruction of the cell |
|
MHC-restricted
|
a process that requires both the antigen, and the organism's own MHC to be functional
|
|
MHC class II molecules
|
found on antigen-presenting cells;
vesicles containing MHC class II molecule combine with endocytotic vesicles containing antigen, forming a complex which is transported to the cell's surface; can bind to T-cell receptors on the surface of T-cells; does not stimulate the destruction of the cell, but rather stimulates an immune resposne against the antigen |
|
Antigen-presenting cells
|
include macrophages, B cells, monocytes, and dendritic cells;
can take in foreign antigens by endocytosis |
|
Dendritic cells
|
large, motile cells with long cytoplasmic extensions;
scattered throughout most tissues with their highest conc. in lymphatic tissue and skin (Langerhans' cells) |
|
Costimulation
|
additional stimulus that is often needed to cause an immune response, in addition to MHC class II/antigen complexes;
accomplished by molecules released from cells and by molecules attached to the surface of cells |
|
Cytokines
|
proteins or peptides secreted by one cell as a regulator of neighboring cell;
promote costimulation; involved in the regulation of immunity, inflammation, tissue repari, cell growth, etc. |
|
Lymphokines
|
cytokines produced by lymphocytes
|
|
Tolerance
|
a state of unresponsiveness of lymphocytes to a specific antigen;
most important funciton of tolerance is to prevent the immune system from responding to self-antigens; can be induced by deletion of self-reactive lymphocytes, preventing activation of lymphocytes, or by activation of suppressor T cells |
|
Anergy
|
"without working";
a condition of inactivity in which a B or T cell does not respond to an antigen |
|
Suppressor T cells
|
cells with the ability to suppress immune responses;
currently not well understood; likely that they are subpopulations of helper T cells and cytotoxic T cells |
|
Gamma globulins
Immunoglobulins (Ig) |
other names for antibodies
|
|
Variable region
|
the portion of the antibody that combines with the antigenic determinant of the antigen; different antibodies have different variable regions that are specific for different antigens
|
|
Constant region
|
portion of an antibody that is responsible for activities of antibodies like ability to activat complement or to attach the antibody to such cells as macrophages, basophils, mast cells, and eosinophils
|
|
Opsonins
|
substances that make an antigen more susceptible to phagocytosis; IgG can act as an opsonin
|
|
Primary response
|
results from the first exposure of a B cell to an antigen for which it is specific and includes a series of cell divisions, cell differentiation, and antibody production;
normally takes 3-14 days to produce enough antibodies to be effective against the antigen |
|
Plasma cells
|
large lymphocytes produced by the mitotic division of B cells;
produces antibodies |
|
Memory B cells
|
small lymphocytes that are produced when B cells undergo mitosis;
|
|
Secondary (memory) response
|
occurs when the immune system is exposed to an antigen against which it has already produced a primary response;
results from memory B cells, which rapidly divide to form plasma cells and large amounts of the antibody; requires only a few hours to days to produce sufficient numbers of antibodies and produces a much larger number of antibodies than primary response |
|
Cytotoxic T cells
|
T cells that lyse cells and produce cytokines
|
|
Perforin
|
a protein which is similar to the complement protein C9 and is used by cytotoxic T cells to cause cell lysis;
forms a channel in the plasma membrane of the target cell through which water enters the cell |
|
Delayed hypersensitivity T cells
|
T cells that respond to antigens by releasing cytokines;
promote phagocytosis and inflammation, especially in allergic reactions |
|
Immunotherapy
|
treats disease by altering immune system function or by directly attacking harmful cells
|
|
Humanization
|
a process in which monoclonal antibodies are modified to resemble human antibodies;
allows monoclonal antibodies to sneak past the immune system |
|
Immunization
|
a deliberate introduction of an antigen or antibody into the body
|
|
Active immunity
|
occurs when an individual is naturally or artificially exposed to an antigen and an adaptive immune system response can occur that produces antibodies
|
|
Passive immunity
|
occurs when another person or animal develops antibodies and the antibodies are transferred to a nonimmune individual
|
|
Active natural immunity
|
achieved when a natural exposure to an antigen can cause an individual's immune system to mount an adaptive immune system response against the antigen
|
|
Active artificial immunity
|
an antigen is deliberately introduced into an individual to stimulate the immune system (vaccination)
|
|
Passive natural immunity
|
results from the tranfer of antibodies from a mother to her child across the placenta before birth or through breastfeeding
|
|
Passive artifical immunity
|
a process by which an animal is injected with an antigen (vaccine) and once its immune system produces a response, antibodies are removed and injected into the individual requiring immunity
|
|
Antiserum
|
the general term used for serum, which is plasma minus the clotting factors;
contains antibodies responsible for passive artifical immunity |